FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年12月5日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件 ...

Group 1 - The company, 康臣药业 (01681), announced a share buyback of 150,000 shares at a cost of HKD 2.2182 million on December 4, 2025 [1]

Group 1 - The company, 康臣药业 (01681), announced a share buyback plan, committing to repurchase 150,000 shares at a cost of HKD 2.2182 million [1]

FF305 表格類別： 股票 狀態： 新提交 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年12月4日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總 ...

Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2][3]. Share Buyback Summary - On December 3, 康臣药业 repurchased 290,000 shares at a price range of HKD 14.660 to HKD 14.740, totaling HKD 4.2674 million [2]. - The stock closed at HKD 14.740 on the same day, reflecting a decrease of 1.54%, with a total trading volume of HKD 15.2119 million [2]. - Since December 2, the company has conducted buybacks for two consecutive days, acquiring a total of 490,000 shares for a cumulative amount of HKD 7.2518 million, during which the stock price fell by 2.38% [2]. Year-to-Date Buyback Activity - Year-to-date, 康臣药业 has executed 50 buyback transactions, acquiring a total of 12.078 million shares for a total expenditure of HKD 161 million [3].

Group 1 - The company, 康臣药业 (01681), announced a share buyback of 290,000 shares at a cost of HKD 4.2674 million, scheduled for December 3, 2025 [1]

Core Viewpoint - 康臣药业 announced a share buyback on December 3, spending HKD 4.267 million to repurchase 290,000 shares at a price range of HKD 14.66 to 14.74 per share [1] Summary by Category - **Company Actions** - 康臣药业 executed a buyback of 290,000 shares at a total cost of HKD 4.267 million [1] - The buyback price per share ranged from HKD 14.66 to 14.74 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年12月3日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存 ...

Core Viewpoint - Multiple companies conducted share buybacks on December 2, 2025, with Tencent Holdings leading in both volume and monetary value [1] Group 1: Buyback Details - Tencent Holdings (00700) repurchased 1.028 million shares for a total of 636 million [2] - Xiaomi Group-W (01810) repurchased 2.5 million shares for a total of 102 million [2] - COSCO Shipping Holdings (01919) repurchased 3 million shares for a total of 41.053 million [2] - China Feihe (06186) repurchased 4 million shares for a total of 16.74 million [2] - Gushengtang (02273) repurchased 378,400 shares for a total of 10.9452 million [2] Group 2: Cumulative Buyback Data - Tencent Holdings has a cumulative buyback of 82.018 million shares, representing 0.893% of its total share capital [2] - Xiaomi Group-W has a cumulative buyback of 78.2954 million shares, representing 0.300% of its total share capital [2] - COSCO Shipping Holdings has a cumulative buyback of 60.543 million shares, representing 2.102% of its total share capital [2] - China Feihe has a cumulative buyback of 195 million shares, representing 2.149% of its total share capital [2] - Gushengtang has a cumulative buyback of 10.4139 million shares, representing 4.395% of its total share capital [2] Group 3: Other Notable Buybacks - Other companies such as Kingsoft (03888), Fuhua Group (02038), and Weigao Group (01066) also participated in the buyback activities, with varying amounts and percentages of total shares repurchased [2][3] - The buyback activities reflect a trend among companies to return capital to shareholders amid market conditions [1]

Group 1 - The company, Kangchen Pharmaceutical (01681.HK), announced a share buyback on December 2, spending HKD 2.984 million to repurchase 200,000 shares [1]